Geri
Frontage Holdings Corporation (FGHQF) Fiyatı
FGHQF Hisse Senedi Fiyat Grafiği
FGHQF Kazanmak
Frontage Holdings Corporation
$0.14
0%
$0
Kapanışta: Jan 23, 16:00:00 GMT-5
$0.14
0%
$0
Sonrası Piyasa: Jan 23, 20:00:00 GMT-5
Earnings FAQ
FGHQF'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Frontage Holdings Corporation FGHQF'ün son çeyrekteki geliri nasıl performans gösterdi?
Frontage Holdings Corporation'in gelir tahmini nedir?
Frontage Holdings Corporation'in kazanç kalite puanı nedir?
Frontage Holdings Corporation kazançlarını ne zaman rapor eder?
Frontage Holdings Corporation'in beklenen kazançları nelerdir?
Frontage Holdings Corporation kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
$0.1498
Açılış fiyatı
$0.1498
Günün Aralığı
$0.1498 - $0.1498
52 haftalık aralık
$0.101 - $0.1498
İşlem hacmi
130
Ort.Hacim
0
EPS (TTM)
0.00
Dividend yield
--
Piyasa Değeri
$303.7M
FRONTAGE HOLDINGS CORP nedir?
Frontage Holdings Corp. engages in the provision of research and analytical and development services throughout the drug discovery and development process. The company is headquartered in Exton, Pennsylvania and currently employs 1,540 full-time employees. The company went IPO on 2019-05-30. The company provides laboratory and related services to pharmaceutical and agrochemical companies, as well as bioequivalence clinical and chemical services. The firm has two main divisions: Global Laboratory Services and Global Drug Discovery & Development Services. The Global Laboratory Services division offers laboratory testing support for clients involved in drug development. The Global Drug Discovery & Development Services division includes Drug Development Unit, the Drug Discovery Unit, and the Pharmaceutical Product Development Unit. Its Global Laboratory Services encompass regulated and non-regulated bioanalysis (both small and large molecules), biomarkers, genomics, manufacturing and controls analytical testing, and central laboratory services. The Drug Development Unit includes drug metabolism and pharmacokinetics, Safety and Toxicology. The firm's segments include North America and Europe and PRC.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved